USANA Health Sciences Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $57.08
- Today's High:
- $58.56
- Open Price:
- $58.56
- 52W Low:
- $48.61
- 52W High:
- $69.6
- Prev. Close:
- $58.56
- Volume:
- 68982
Company Statistics
- Market Cap.:
- $1.13 billion
- Book Value:
- 24.294
- Revenue TTM:
- $947.82 million
- Operating Margin TTM:
- 10.17%
- Gross Profit TTM:
- $804.71 million
- Profit Margin:
- 6.69%
- Return on Assets TTM:
- 10.39%
- Return on Equity TTM:
- 14.53%
Company Profile
USANA Health Sciences Inc had its IPO on 1996-07-25 under the ticker symbol USNA.
The company operates in the Consumer Defensive sector and Packaged Foods industry. USANA Health Sciences Inc has a staff strength of 1,900 employees.
Stock update
Shares of USANA Health Sciences Inc opened at $58.56 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $57.08 - $58.56, and closed at $57.94.
This is a -1.06% slip from the previous day's closing price.
A total volume of 68,982 shares were traded at the close of the day’s session.
In the last one week, shares of USANA Health Sciences Inc have slipped by -10.48%.
USANA Health Sciences Inc's Key Ratios
USANA Health Sciences Inc has a market cap of $1.13 billion, indicating a price to book ratio of 2.4472 and a price to sales ratio of 0.933.
In the last 12-months USANA Health Sciences Inc’s revenue was $947.82 million with a gross profit of $804.71 million and an EBITDA of $109.71 million. The EBITDA ratio measures USANA Health Sciences Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, USANA Health Sciences Inc’s operating margin was 10.17% while its return on assets stood at 10.39% with a return of equity of 14.53%.
In Q2, USANA Health Sciences Inc’s quarterly earnings growth was a negative -10.7% while revenue growth was a negative 9.9%.
USANA Health Sciences Inc’s PE and PEG Ratio
- Forward PE
- 16.0514
- Trailing PE
- 18.3
- PEG
- 1.0695
Its diluted EPS in the last 12-months stands at $3.2 per share while it has a forward price to earnings multiple of 16.0514 and a PEG multiple of 1.0695. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into USANA Health Sciences Inc’s profitability.
USANA Health Sciences Inc stock is trading at a EV to sales ratio of 0.7498 and a EV to EBITDA ratio of 5.5805. Its price to sales ratio in the trailing 12-months stood at 0.933.
USANA Health Sciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $602.68 million
- Total Liabilities
- $113.84 million
- Operating Cash Flow
- $179000.00
- Capital Expenditure
- $3.61 million
- Dividend Payout Ratio
- 0%
USANA Health Sciences Inc ended 2024 with $602.68 million in total assets and $0 in total liabilities. Its intangible assets were valued at $602.68 million while shareholder equity stood at $468.82 million.
USANA Health Sciences Inc ended 2024 with $4.80 million in deferred long-term liabilities, $113.84 million in other current liabilities, 19000.00 in common stock, $427.31 million in retained earnings and $16.86 million in goodwill. Its cash balance stood at $300.18 million and cash and short-term investments were $300.18 million. The company’s total short-term debt was $0 while long-term debt stood at $0.
USANA Health Sciences Inc’s total current assets stands at $387.65 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $72.44 million compared to accounts payable of $9.27 million and inventory worth $61.96 million.
In 2024, USANA Health Sciences Inc's operating cash flow was $179000.00 while its capital expenditure stood at $3.61 million.
Comparatively, USANA Health Sciences Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $57.94
- 52-Week High
- $69.6
- 52-Week Low
- $48.61
- Analyst Target Price
- $56
USANA Health Sciences Inc stock is currently trading at $57.94 per share. It touched a 52-week high of $69.6 and a 52-week low of $69.6. Analysts tracking the stock have a 12-month average target price of $56.
Its 50-day moving average was $63.35 and 200-day moving average was $61.02 The short ratio stood at 3.35 indicating a short percent outstanding of 0%.
Around 4160.1% of the company’s stock are held by insiders while 5600.1% are held by institutions.
Frequently Asked Questions About USANA Health Sciences Inc
Similar Industry Stocks (Packaged Foods)
Most Active
Top Gainers
Top Losers
About
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.